Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Acquisition costs

Share-based compensation

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

This Canadian pot stock has defied the broader downturn among its peer group in 2024.

Is It Time to Load Up on Aurora Cannabis Stock?

Canopy Growth

AdvisorShares Pure US Cannabis ETF

The cannabis sector has captivated investors, promising a green rush of potential profits. However, the path to profitability has been rocky, marked by regulatory hurdles, intense competition, and, at times, a volatile market.

Profit from the Green Wave: Top Cannabis Stocks to Watch

Aurora Cannabis' new collaboration on the Genome BC-Funded Project addresses distinct cannabis aromas.

ACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project

NASDAQ | TSX: ACB Research Project designed to validate breeding genetics connected with fruity aroma, a key patient and consumer preference trait, with positive impact on future innovation  EDMONTON, AB , Oct. 2, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –—the Canadian based leading global medical cannabis company, today announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia (Genome BC), a not-for-profit organization supporting world-class genomics research and innovation in British Columbia. The project, Genomics-enabled Aroma Breeding in Cannabis, will directly support Aurora's genetics work the project, is led by Drs.

Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas

NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB , Sept. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director.

Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors

Tilray Brands

The Canadian cannabis market remains a focal point for investors this week, especially with companies expanding into the U.S. market. Recently, the U.S. cannabis industry has shown remarkable growth, with sales projected to reach $45 billion by 2025. This expansion offers Canadian companies a gateway to a larger consumer base. The increasing push for legalization in the U.S. is also a significant factor. States are continuously passing legislation to legalize cannabis for recreational and medicinal use. Therefore, investors watch how Canadian stocks position themselves for potential U.S. market entry.

Canadian Cannabis Stocks Set to Soar Right Now

Auto-Flowering Breakthroughs Poised to Transform Cannabis Cultivation in High-Latitude Regions, Opening New Doors for Advanced Breeding Strategies EDMONTON, AB , Sept. 17, 2024 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pioneering ground-breaking research in auto-flowering technology.

Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

Trulieve Cannabis Corp.

GOP presidential nominee Donald Trump supports Schedule III classification for cannabis, which has already been proposed by the Biden administration.

Cannabis stocks rally after Trump supports moving drug to less restrictive category

Launch represents Vectura Fertin Pharma's first medical cannabis CBD lozenge to be introduced in Canada Launch follows announcement of commercial collaboration between Cogent International, a Vectura Fertin Pharma subsidiary, and Aurora to leverage Aurora's Canadian medical cannabis patient platform Collaboration will explore the potential to launch Vectura Fertin Pharma's future medical cannabis portfolio in Canada Edmonton, AB, and Stamford, CT – September 9, 2024 - Aurora Cannabis Inc. ("Aurora") (NASDAQ | TSX: ACB), a leading Canadian-based global medical cannabis company, and Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, are pleased to announce the launch of the newly developed Luo CBD lozenge. The high-quality CBD lozenge was developed by Vectura Fertin Pharma and adheres to stringent safety, quality and regulatory standards to address unmet medical and health needs.

Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge

Cronos Group

OrganiGram Holdings Inc.

Many legal cannabis operators are working to keep pushing the boundaries of the industry. Innovation is key for any growing sector and cannabis is no different. Right now is a pivotal time for the cannabis industry as things are continuously changing. The climate of the sector and the success of companies can have a direct connection to how most marijuana stocks perform, especially during an election year where promises may come along from presidential candidates to better the industry.

3 Marijuana Stocks To Watch In The Stock Market Today

The cannabis market is abuzz following former President Donald Trump's recent comments supporting cannabis legalization in Florida.

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

Alliance Global Partners Aaron Grey sees Donald Trump's weekend statement on cannabis as a step forward.

Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan' issue

When it comes to finding top marijuana stocks to buy which companies would you choose? Now when going through this process there are some things to consider. For the most part, investing in all things is based on the same basic outline which is buy low sell high do your research create a game plan be patient, and try to take profits when you can.

Top Canadian Marijuana Stocks To Watch In 2024

The U.S. Drug Enforcement Administration (DEA) today announced a proposal hearing on the reclassification of marijuana as a less restricted Schedule III drug will happen on Dec. 2, after the presidential election.

3 Weed Stocks Sinking on Reclassification Hearing Update

Aurora Cannabis and Canopy Growth have been leading companies within the cannabis industry for years. Both businesses have struggled, however, and have been working on improving their financials.

Prediction: Aurora Cannabis Will Be Worth More Than Canopy Growth in 5 Years

Aurora Cannabis has made significant strides in improving its financials. The company generated positive free cash flow and revenue rose last quarter.

Aurora Cannabis Had a Strong Q1, but Investors Should Expect a Slowdown in Future Quarters

Earnings from North American cannabis companies for the second quarter have been a mixed bag, with expansion into new markets, operational streamlining, and product innovation key themes across the sector. Many multi-state operations (MSOs) are turning to emerging, less saturated international markets for growth, notably, Germany, which kicked off expanded medical sales amid broader legalization measures on April 1.

Cannabis MSOs embrace new markets, streamline operations in Q2

NASDAQ | TSX: ACB EDMONTON, AB , Aug. 12, 2024 /PRNewswire/ -  Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of the record date.

Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting

The cannabis industry has experienced significant change since its inception twelve years ago.  Fueled by legalization trends and evolving social acceptance, this burgeoning sector has attracted considerable investment and innovation.

The Cannabis Sector: Profitability Takes Center Stage

Aurora Cannabis achieves milestone positive free cash flow for the first time in Q1 FY2025. Strong growth in medical cannabis, particularly in Australia and Europe, positions the company well for future profitability. Potential US rescheduling of cannabis could impact Aurora's stock price and open up opportunities in the US market.

Aurora Cannabis: Revving Up To Profitability

Lumen Technologies

Aurora Cannabis Inc (NASDAQ:ACB) and Lumen Technologies Inc (NYSE:LUMN) are this week's picks for Schaeffer's Cheap Seats : Stocks Under $20 segment.

2 Stocks Under $10 Soaring Today

Aurora Cannabis Inc. (NASDAQ:ACB ) Q1 2025 Results Conference Call August 7, 2024 8:00 AM ET Company Participants Kevin Niland - Director, Strategic Finance and IR Miguel Martin - Chief Executive Officer Simona King - Chief Financial Officer Conference Call Participants Pablo Zuanic - Zuanic & Associates Operator Hello, everyone, and welcome to the Aurora Cannabis Incorporated Fiscal First Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode.

Aurora Cannabis Inc. (ACB) Q1 2025 Earnings Call Transcript

Aurora Cannabis Inc. (NASDAQ: ACB) reported a return to profitability in its first fiscal quarter, driven by the strength of its medical cannabis division.  Shares of the licensed cannabis producer surged 11% on Wednesday following the announcement.

Aurora Cannabis posts profit with 87% EBITDA growth, shares jump 11%: Is it too late to invest?

Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.40 per share a year ago.

Aurora Cannabis Inc. (ACB) Reports Q1 Loss, Tops Revenue Estimates

Delivers Positive Free Cash Flow1 of $6.5 Million Increases Total Quarterly Net Revenue1 by 12% YoY to $83.4 Million, Record Net Revenue1 of $47.2 Million in Global Medical Cannabis  Generates Adjusted EBITDA1 of $4.9 Million, a YoY increase of 87% Ends the Fiscal Quarter with a Debt-Free Cannabis Business2 and a Cash Position of ~$182 Million EDMONTON, AB , Aug. 7, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter fiscal 2025. "This was a milestone quarter for Aurora, as we delivered strong net revenue1 growth, a substantial increase in adjusted EBITDA1, and positive free cash flow1.

News for Aurora Cannabis Stock (ACB)